title: Impact of Pulmonary Exacerbations On Eq-5d Measures In Patients With Cystic Fibrosis.
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: C T
authors.initials: CT
authors.lastname: Solem
authors.affiliation: Vertex Pharmaceuticals, Boston, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Vera-Llonch
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: S
authors.initials: S
authors.lastname: Liu
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: Botteman
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: F J
authors.initials: FJ
authors.lastname: Lin
authors.affiliation: Vertex Pharmaceuticals, Boston, MA, USA.
authors.forename: B
authors.initials: B
authors.lastname: Castiglione